Top compounds associated with response to SLC12A7


Feature Type Standardized
Nominal ANOVA
mRNA JQ12 GDSC1000 pan-cancer AAC 0.099 0.007
mRNA Sorafenib GDSC1000 pan-cancer AAC 0.15 0.007
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.093 0.007
mRNA lenalidomide FIMM pan-cancer AAC 0.44 0.008
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.083 0.009
mRNA lovastatin CTRPv2 pan-cancer AAC -0.097 0.009
mRNA ML210 CTRPv2 pan-cancer AAC -0.085 0.01
mRNA LAQ824 GDSC1000 pan-cancer AAC 0.091 0.01
mRNA NSC-207895 GDSC1000 pan-cancer AAC -0.088 0.01
mRNA niclosamide CTRPv2 pan-cancer AAC -0.092 0.01
Download CSV